nodes	percent_of_prediction	percent_of_DWPC	metapath
Butabarbital—CHRNA7—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA5—chronic obstructive pulmonary disease	0.0326	0.0624	CbGpPWpGaD
Butabarbital—CHRNA4—Highly calcium permeable nicotinic acetylcholine receptors—CHRNA5—chronic obstructive pulmonary disease	0.0312	0.0597	CbGpPWpGaD
Butabarbital—CHRNA4—Highly sodium permeable acetylcholine nicotinic receptors—CHRNA3—chronic obstructive pulmonary disease	0.0311	0.0595	CbGpPWpGaD
Butabarbital—CHRNA7—Acetylcholine Binding And Downstream Events—CHRNA5—chronic obstructive pulmonary disease	0.0269	0.0514	CbGpPWpGaD
Butabarbital—CHRNA7—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA3—chronic obstructive pulmonary disease	0.0266	0.0508	CbGpPWpGaD
Butabarbital—CHRNA4—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA5—chronic obstructive pulmonary disease	0.0266	0.0508	CbGpPWpGaD
Butabarbital—CHRNA4—Highly calcium permeable nicotinic acetylcholine receptors—CHRNA3—chronic obstructive pulmonary disease	0.0255	0.0487	CbGpPWpGaD
Butabarbital—CHRNA4—Presynaptic nicotinic acetylcholine receptors—CHRNA5—chronic obstructive pulmonary disease	0.0248	0.0474	CbGpPWpGaD
Butabarbital—CHRNA4—Acetylcholine Binding And Downstream Events—CHRNA5—chronic obstructive pulmonary disease	0.0219	0.0419	CbGpPWpGaD
Butabarbital—CHRNA7—Acetylcholine Binding And Downstream Events—CHRNA3—chronic obstructive pulmonary disease	0.0219	0.0419	CbGpPWpGaD
Butabarbital—CHRNA4—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA3—chronic obstructive pulmonary disease	0.0217	0.0414	CbGpPWpGaD
Butabarbital—CHRNA4—Presynaptic nicotinic acetylcholine receptors—CHRNA3—chronic obstructive pulmonary disease	0.0202	0.0387	CbGpPWpGaD
Butabarbital—CHRNA4—Acetylcholine Binding And Downstream Events—CHRNA3—chronic obstructive pulmonary disease	0.0179	0.0342	CbGpPWpGaD
Butabarbital—CHRNA4—Nicotine Activity on Dopaminergic Neurons—CHRNA5—chronic obstructive pulmonary disease	0.0159	0.0303	CbGpPWpGaD
Butabarbital—CHRNA4—Nicotine Activity on Dopaminergic Neurons—CHRNA3—chronic obstructive pulmonary disease	0.0129	0.0247	CbGpPWpGaD
Butabarbital—Liver injury—Montelukast—chronic obstructive pulmonary disease	0.0113	0.024	CcSEcCtD
Butabarbital—Dermatitis exfoliative—Aminophylline—chronic obstructive pulmonary disease	0.00985	0.0209	CcSEcCtD
Butabarbital—Hepatocellular injury—Montelukast—chronic obstructive pulmonary disease	0.00954	0.0202	CcSEcCtD
Butabarbital—Nightmare—Salbutamol—chronic obstructive pulmonary disease	0.00888	0.0188	CcSEcCtD
Butabarbital—Hyperkinesia—Montelukast—chronic obstructive pulmonary disease	0.00832	0.0176	CcSEcCtD
Butabarbital—Tension—Roflumilast—chronic obstructive pulmonary disease	0.00823	0.0174	CcSEcCtD
Butabarbital—Nervousness—Roflumilast—chronic obstructive pulmonary disease	0.00815	0.0173	CcSEcCtD
Butabarbital—Hyperkinesia—Salbutamol—chronic obstructive pulmonary disease	0.00802	0.017	CcSEcCtD
Butabarbital—Angioedema—Roflumilast—chronic obstructive pulmonary disease	0.00767	0.0162	CcSEcCtD
Butabarbital—Anxiety—Roflumilast—chronic obstructive pulmonary disease	0.00712	0.0151	CcSEcCtD
Butabarbital—Ataxia—Salbutamol—chronic obstructive pulmonary disease	0.00628	0.0133	CcSEcCtD
Butabarbital—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00586	0.0124	CcSEcCtD
Butabarbital—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.00564	0.012	CcSEcCtD
Butabarbital—GABRB2—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.0055	0.0105	CbGpPWpGaD
Butabarbital—Tension—Aminophylline—chronic obstructive pulmonary disease	0.00549	0.0116	CcSEcCtD
Butabarbital—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.00543	0.0115	CcSEcCtD
Butabarbital—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.00514	0.0109	CcSEcCtD
Butabarbital—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00505	0.0107	CcSEcCtD
Butabarbital—GABRG2—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.00503	0.00962	CbGpPWpGaD
Butabarbital—GABRB2—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00491	0.00937	CbGpPWpGaD
Butabarbital—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.00482	0.0102	CcSEcCtD
Butabarbital—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.00477	0.0101	CcSEcCtD
Butabarbital—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.00475	0.0101	CcSEcCtD
Butabarbital—Syncope—Tiotropium—chronic obstructive pulmonary disease	0.00473	0.01	CcSEcCtD
Butabarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00469	0.00896	CbGpPWpGaD
Butabarbital—Loss of consciousness—Tiotropium—chronic obstructive pulmonary disease	0.00464	0.00983	CcSEcCtD
Butabarbital—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00453	0.00959	CcSEcCtD
Butabarbital—Shock—Aminophylline—chronic obstructive pulmonary disease	0.00449	0.00952	CcSEcCtD
Butabarbital—GABRG2—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00449	0.00857	CbGpPWpGaD
Butabarbital—GABRA1—Ion channel transport—ATP2C2—chronic obstructive pulmonary disease	0.0044	0.00841	CbGpPWpGaD
Butabarbital—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00435	0.00922	CcSEcCtD
Butabarbital—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00432	0.00915	CcSEcCtD
Butabarbital—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00431	0.00914	CcSEcCtD
Butabarbital—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00429	0.00909	CcSEcCtD
Butabarbital—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00427	0.00904	CcSEcCtD
Butabarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00426	0.00815	CbGpPWpGaD
Butabarbital—Shock—Tiotropium—chronic obstructive pulmonary disease	0.00424	0.00898	CcSEcCtD
Butabarbital—Tension—Arformoterol—chronic obstructive pulmonary disease	0.00418	0.00885	CcSEcCtD
Butabarbital—Tension—Formoterol—chronic obstructive pulmonary disease	0.00418	0.00885	CcSEcCtD
Butabarbital—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.00414	0.00876	CcSEcCtD
Butabarbital—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.00414	0.00876	CcSEcCtD
Butabarbital—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00407	0.00862	CcSEcCtD
Butabarbital—Tension—Salbutamol—chronic obstructive pulmonary disease	0.00395	0.00836	CcSEcCtD
Butabarbital—GABRA1—Ion channel transport—TRPV4—chronic obstructive pulmonary disease	0.00392	0.00749	CbGpPWpGaD
Butabarbital—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.00391	0.00829	CcSEcCtD
Butabarbital—Agitation—Formoterol—chronic obstructive pulmonary disease	0.00391	0.00829	CcSEcCtD
Butabarbital—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.00391	0.00827	CcSEcCtD
Butabarbital—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.00389	0.00824	CcSEcCtD
Butabarbital—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.00389	0.00824	CcSEcCtD
Butabarbital—Agitation—Montelukast—chronic obstructive pulmonary disease	0.00383	0.00812	CcSEcCtD
Butabarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00382	0.0073	CbGpPWpGaD
Butabarbital—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.00381	0.00808	CcSEcCtD
Butabarbital—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.0037	0.00783	CcSEcCtD
Butabarbital—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00368	0.0078	CcSEcCtD
Butabarbital—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.00367	0.00778	CcSEcCtD
Butabarbital—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.00361	0.00765	CcSEcCtD
Butabarbital—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.00361	0.00765	CcSEcCtD
Butabarbital—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00361	0.00765	CcSEcCtD
Butabarbital—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.00361	0.00764	CcSEcCtD
Butabarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00358	0.00685	CbGpPWpGaD
Butabarbital—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00354	0.0075	CcSEcCtD
Butabarbital—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00353	0.00749	CcSEcCtD
Butabarbital—GRIK2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00352	0.00673	CbGpPWpGaD
Butabarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00348	0.00664	CbGpPWpGaD
Butabarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00348	0.00664	CbGpPWpGaD
Butabarbital—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00341	0.00723	CcSEcCtD
Butabarbital—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00336	0.00713	CcSEcCtD
Butabarbital—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.00334	0.00708	CcSEcCtD
Butabarbital—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00325	0.00688	CcSEcCtD
Butabarbital—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00325	0.00688	CcSEcCtD
Butabarbital—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00323	0.00684	CcSEcCtD
Butabarbital—CHRNA7—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00321	0.00613	CbGpPWpGaD
Butabarbital—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00317	0.00672	CcSEcCtD
Butabarbital—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00309	0.00655	CcSEcCtD
Butabarbital—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00309	0.00655	CcSEcCtD
Butabarbital—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00307	0.0065	CcSEcCtD
Butabarbital—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00303	0.00641	CcSEcCtD
Butabarbital—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00302	0.0064	CcSEcCtD
Butabarbital—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00297	0.0063	CcSEcCtD
Butabarbital—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00297	0.0063	CcSEcCtD
Butabarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00292	0.00558	CbGpPWpGaD
Butabarbital—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00292	0.00618	CcSEcCtD
Butabarbital—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.0029	0.00615	CcSEcCtD
Butabarbital—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00288	0.0061	CcSEcCtD
Butabarbital—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00288	0.00609	CcSEcCtD
Butabarbital—GRIK2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.00287	0.00549	CbGpPWpGaD
Butabarbital—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00286	0.00607	CcSEcCtD
Butabarbital—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00286	0.00607	CcSEcCtD
Butabarbital—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00286	0.00606	CcSEcCtD
Butabarbital—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00285	0.00603	CcSEcCtD
Butabarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00283	0.00542	CbGpPWpGaD
Butabarbital—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00281	0.00595	CcSEcCtD
Butabarbital—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00275	0.00582	CcSEcCtD
Butabarbital—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00275	0.00582	CcSEcCtD
Butabarbital—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00274	0.0058	CcSEcCtD
Butabarbital—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00272	0.00575	CcSEcCtD
Butabarbital—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00271	0.00575	CcSEcCtD
Butabarbital—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00271	0.00575	CcSEcCtD
Butabarbital—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.0027	0.00573	CcSEcCtD
Butabarbital—GRIK2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.0027	0.00516	CbGpPWpGaD
Butabarbital—Headache—Tiotropium—chronic obstructive pulmonary disease	0.0027	0.00572	CcSEcCtD
Butabarbital—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.0027	0.00571	CcSEcCtD
Butabarbital—GRIA2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00269	0.00515	CbGpPWpGaD
Butabarbital—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00269	0.00515	CbGpPWpGaD
Butabarbital—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00269	0.0057	CcSEcCtD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.00263	0.00502	CbGpPWpGaD
Butabarbital—CHRNA4—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00261	0.00499	CbGpPWpGaD
Butabarbital—CHRNA7—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.00261	0.00499	CbGpPWpGaD
Butabarbital—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00259	0.0055	CcSEcCtD
Butabarbital—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00256	0.00543	CcSEcCtD
Butabarbital—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00256	0.00543	CcSEcCtD
Butabarbital—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00256	0.00542	CcSEcCtD
Butabarbital—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00251	0.00531	CcSEcCtD
Butabarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00246	0.00471	CbGpPWpGaD
Butabarbital—CHRNA7—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00246	0.00469	CbGpPWpGaD
Butabarbital—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00242	0.00512	CcSEcCtD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.00237	0.00453	CbGpPWpGaD
Butabarbital—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.0023	0.00487	CcSEcCtD
Butabarbital—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.0023	0.00487	CcSEcCtD
Butabarbital—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00225	0.00477	CcSEcCtD
Butabarbital—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00221	0.00468	CcSEcCtD
Butabarbital—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00221	0.00468	CcSEcCtD
Butabarbital—GRIK2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.0022	0.00421	CbGpPWpGaD
Butabarbital—GRIA2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.0022	0.0042	CbGpPWpGaD
Butabarbital—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00219	0.00419	CbGpPWpGaD
Butabarbital—Rash—Formoterol—chronic obstructive pulmonary disease	0.00219	0.00464	CcSEcCtD
Butabarbital—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00219	0.00464	CcSEcCtD
Butabarbital—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00219	0.00464	CcSEcCtD
Butabarbital—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00219	0.00464	CcSEcCtD
Butabarbital—Headache—Formoterol—chronic obstructive pulmonary disease	0.00218	0.00461	CcSEcCtD
Butabarbital—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00218	0.00461	CcSEcCtD
Butabarbital—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00217	0.0046	CcSEcCtD
Butabarbital—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00216	0.00459	CcSEcCtD
Butabarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00215	0.00411	CbGpPWpGaD
Butabarbital—Rash—Montelukast—chronic obstructive pulmonary disease	0.00215	0.00455	CcSEcCtD
Butabarbital—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00214	0.00454	CcSEcCtD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.00214	0.00409	CbGpPWpGaD
Butabarbital—Headache—Montelukast—chronic obstructive pulmonary disease	0.00213	0.00452	CcSEcCtD
Butabarbital—CHRNA4—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.00213	0.00407	CbGpPWpGaD
Butabarbital—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.00211	0.00446	CcSEcCtD
Butabarbital—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00209	0.00442	CcSEcCtD
Butabarbital—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00207	0.00438	CcSEcCtD
Butabarbital—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.00207	0.00438	CcSEcCtD
Butabarbital—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00207	0.00438	CcSEcCtD
Butabarbital—GRIA2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00206	0.00395	CbGpPWpGaD
Butabarbital—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00206	0.00437	CcSEcCtD
Butabarbital—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00206	0.00437	CcSEcCtD
Butabarbital—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00206	0.00436	CcSEcCtD
Butabarbital—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.00203	0.00429	CcSEcCtD
Butabarbital—GABRB2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00202	0.00387	CbGpPWpGaD
Butabarbital—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00202	0.00428	CcSEcCtD
Butabarbital—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00201	0.00384	CbGpPWpGaD
Butabarbital—CHRNA4—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.002	0.00383	CbGpPWpGaD
Butabarbital—CHRNA7—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.002	0.00383	CbGpPWpGaD
Butabarbital—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.00196	0.00415	CcSEcCtD
Butabarbital—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00195	0.00413	CcSEcCtD
Butabarbital—Secobarbital—CYP1A2—chronic obstructive pulmonary disease	0.00194	0.41	CrCbGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.00193	0.00369	CbGpPWpGaD
Butabarbital—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.00192	0.00406	CcSEcCtD
Butabarbital—GABRB2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00192	0.00366	CbGpPWpGaD
Butabarbital—Shock—Prednisolone—chronic obstructive pulmonary disease	0.00185	0.00392	CcSEcCtD
Butabarbital—GABRG2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00185	0.00354	CbGpPWpGaD
Butabarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00175	0.00335	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00175	0.00335	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00171	0.00326	CbGpPWpGaD
Butabarbital—GRIA2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00168	0.00322	CbGpPWpGaD
Butabarbital—GABRB2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.00165	0.00315	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.00164	0.00314	CbGpPWpGaD
Butabarbital—CHRNA4—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00163	0.00312	CbGpPWpGaD
Butabarbital—GABRA1—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00162	0.00309	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00156	0.00298	CbGpPWpGaD
Butabarbital—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.00155	0.00329	CcSEcCtD
Butabarbital—GABRB2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00155	0.00296	CbGpPWpGaD
Butabarbital—Agitation—Prednisone—chronic obstructive pulmonary disease	0.00154	0.00326	CcSEcCtD
Butabarbital—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.00153	0.00324	CcSEcCtD
Butabarbital—GABRA1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00153	0.00293	CbGpPWpGaD
Butabarbital—GABRG2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.00151	0.00288	CbGpPWpGaD
Butabarbital—Syncope—Prednisone—chronic obstructive pulmonary disease	0.0015	0.00318	CcSEcCtD
Butabarbital—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.00147	0.00312	CcSEcCtD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.00145	0.00278	CbGpPWpGaD
Butabarbital—Phenobarbital—CYP1A1—chronic obstructive pulmonary disease	0.00142	0.3	CrCbGaD
Butabarbital—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.00142	0.00301	CcSEcCtD
Butabarbital—GABRG2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00142	0.00271	CbGpPWpGaD
Butabarbital—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00139	0.00294	CcSEcCtD
Butabarbital—Phenobarbital—CYP1A2—chronic obstructive pulmonary disease	0.00137	0.289	CrCbGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00136	0.00261	CbGpPWpGaD
Butabarbital—Shock—Prednisone—chronic obstructive pulmonary disease	0.00135	0.00285	CcSEcCtD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.00134	0.00256	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.00133	0.00253	CbGpPWpGaD
Butabarbital—GABRA1—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.00132	0.00252	CbGpPWpGaD
Butabarbital—GABRB2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00126	0.00242	CbGpPWpGaD
Butabarbital—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.00124	0.00264	CcSEcCtD
Butabarbital—GABRA1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00124	0.00237	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.0012	0.00229	CbGpPWpGaD
Butabarbital—Rash—Prednisolone—chronic obstructive pulmonary disease	0.00119	0.00251	CcSEcCtD
Butabarbital—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00119	0.00251	CcSEcCtD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.00118	0.00226	CbGpPWpGaD
Butabarbital—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00118	0.0025	CcSEcCtD
Butabarbital—Constipation—Prednisone—chronic obstructive pulmonary disease	0.00117	0.00248	CcSEcCtD
Butabarbital—GABRG2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00116	0.00221	CbGpPWpGaD
Butabarbital—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.00113	0.00239	CcSEcCtD
Butabarbital—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00112	0.00237	CcSEcCtD
Butabarbital—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.00108	0.00229	CcSEcCtD
Butabarbital—GABRA1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00101	0.00193	CbGpPWpGaD
Butabarbital—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.00101	0.00214	CcSEcCtD
Butabarbital—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000904	0.00192	CcSEcCtD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000898	0.00172	CbGpPWpGaD
Butabarbital—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.00087	0.00184	CcSEcCtD
Butabarbital—Rash—Prednisone—chronic obstructive pulmonary disease	0.000862	0.00183	CcSEcCtD
Butabarbital—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000862	0.00183	CcSEcCtD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000861	0.00165	CbGpPWpGaD
Butabarbital—Headache—Prednisone—chronic obstructive pulmonary disease	0.000857	0.00182	CcSEcCtD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000829	0.00158	CbGpPWpGaD
Butabarbital—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000812	0.00172	CcSEcCtD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000734	0.0014	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000732	0.0014	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.000729	0.00139	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000702	0.00134	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	0.000625	0.00119	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.000595	0.00114	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	0.00051	0.000974	CbGpPWpGaD
Butabarbital—CHRNA7—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	0.000504	0.000964	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000453	0.000866	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000435	0.000831	CbGpPWpGaD
Butabarbital—CHRNA4—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	0.000411	0.000786	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000376	0.000718	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.000368	0.000703	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000344	0.000657	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	0.000315	0.000603	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.0003	0.000574	CbGpPWpGaD
Butabarbital—GABRA1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	0.000255	0.000487	CbGpPWpGaD
Butabarbital—GABRB2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000226	0.000431	CbGpPWpGaD
Butabarbital—GABRG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000206	0.000394	CbGpPWpGaD
Butabarbital—GABRA1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.00018	0.000345	CbGpPWpGaD
